Apyx Medical (APYX) Shares Outstanding (Diluted Average) (2010 - 2023)

Apyx Medical has reported Shares Outstanding (Diluted Average) for 14 years, with the latest figure at $34.6 million in Q4 2023.

• For the quarter ending Q4 2023, Shares Outstanding (Diluted Average) changed 0.31% year-over-year to $34.6 million; the trailing twelve-month figure through Dec 2023 stood at $34.6 million (changed 0.31% YoY), and the FY2023 full-year result was $34.6 million, changed 0.31% from the prior year.
• Shares Outstanding (Diluted Average) for Q4 2023 stood at $34.6 million, roughly flat from $34.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $34.6 million in Q4 2023, with the low at $34.1 million in Q4 2019.
• Historically, Shares Outstanding (Diluted Average) has averaged $34.4 million across 5 years, with a median of $34.3 million in 2021.
• Annual changes were most pronounced in 2019 — Shares Outstanding (Diluted Average) declined 0.86% — and 2022, when it climbed 0.54%.
• Apyx Medical's Shares Outstanding (Diluted Average) stood at $34.1 million in 2019, then gained by 0.42% to $34.2 million in 2020, then rose by 0.35% to $34.3 million in 2021, then increased by 0.54% to $34.5 million in 2022, then climbed by 0.31% to $34.6 million in 2023.
• The last three Shares Outstanding (Diluted Average) figures came in at $34.6 million (Q4 2023), $34.5 million (Q4 2022), and $34.3 million (Q4 2021), per Business Quant data.